Olema Pharmaceuticals (OLMA) Earnings Date & Reports
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OLMA is expected to report earnings to rise 21.13% to -62 cents per share on November 10
Q3'26
Est.
$-0.63
Q1'26
Beat
by $0.01
Q4'25
Beat
by $0.02
Q3'25
Missed
by $0.02
Q2'25
Missed
by $0.13
The last earnings report on May 12 showed earnings per share of -51 cents, beating the estimate of -52 cents. With 442.56K shares outstanding, the current market capitalization sits at 935.35M.